WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that Caroline West, global chief compliance officer, Olympus Corporation, was honored with the 2020 Accenture Award for Leadership in the Advancement of Ethics in the MedTech Industry. Presented at The Virtual MedTech Conference, the award is sponsored this year by Accenture and given annually under AdvaMed’s auspices to an individual who has demonstrated outstanding leadership in the advancement of ethics and ethical behavior in the medical technology industry.
WASHINGTON, D.C.– Experts from government, industry and academia provide a comprehensive perspective of the impact of the COVID-19 pandemic as The Virtual MedTech Conference, powered by AdvaMed, concludes three days of livestream content tomorrow.
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 180 million. A breakdown of the data shows that innovative diagnostics companies are shipping, on average, over 1.3 million molecular tests each day.
WASHINGTON, D.C.– Day 2 of The Virtual MedTech Conference, powered by AdvaMed, continues its run of engaging and thought-provoking program offerings tomorrow with an interview with an NBA legend, a competition among cutting-edge start-ups, an in-depth discussion of regulatory issues, and a tribute to an industry pioneer.
WASHINGTON, D.C. – In a wide-ranging interview for The Virtual MedTech Conference this week, FDA Commissioner Dr. Stephen Hahn spoke with AdvaMed President and CEO Scott Whitaker on the importance of Americans’ continued confidence in the integrity of the agency’s science-based product review process.
WASHINGTON, D.C.– The Virtual MedTech Conference, powered by AdvaMed, kicks off three days of livestream events tomorrow with morning to afternoon sessions featuring an international perspective on the COVID-19 pandemic, a look at the next generation of U.S. voters, a fireside chat with FDA Commissioner Hahn, a discussion on diversity and health care disparities, and insights from key CMS officials.
WASHINGTON, D.C. – AdvaMed released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed and AdvaMedDx, received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration of “a rapid point-of-care test to be used with the Sofia® 2 Fluorescent Immunoassay Analyzer for the rapid, simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) and nasal (NS) swab specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider within the first five days of the onset of symptoms.”
WASHINGTON, D.C. – To help realize the potential of digital health technologies to improve patient care, today the Advanced Medical Technology Association (AdvaMed) issued a white paper detailing recommendations to modernize Medicare coverage and payment policies so that beneficiaries can have greater access to the latest digital health innovations.
WASHINGTON, DC. – The Advanced Medical Technology Association (AdvaMed) today announced that former Guidant CEO Ronald “Ron” W. Dollens will receive the 2020 AdvaMed Lifetime Achievement Award at the industry’s premier annual gathering – The Virtual MedTech Conference – during a livestream session Oct. 6 at 2:30 pm ET.
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced that Vena Vitals has been awarded the 2020 MedTech Innovator Execution Award and the Virginia Shimer Rybski Memorial Award.